PD
BSX icon

Point72 (DIFC)’s Boston Scientific BSX Stock Holding History

Point72 (DIFC)’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-500
Closed -$50.4K – 1584
2025
Q1 		$50.4K Sell
500
-8,400
-94% -$846K ﹤0.01% 1203
2024
Q4 		$795K Buy
8,900
+8,200
+1,171% +$722K 0.03% 525
2024
Q3 		$58.7K Sell
700
-16,000
-96% -$1.26M ﹤0.01% 1066
2024
Q2 		$1.29M Buy
16,700
+8,900
+114% +$651K 0.05% 439
2024
Q1 		$534K Buy
+7,800
New +$502K 0.02% 725

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 (DIFC)'s BSX Position: Q3 2025 in Review

Point72 (DIFC) increased its Boston Scientific (BSX) stake by 179% in Q3 2025, buying an estimated $27.2M and bringing the position to 408,664 shares worth $39.9M. The position accounts for 2.61% of the portfolio, ranked #4.

Point72 (DIFC) first reported a position in BSX in Q4 2024 and has held it in 4 quarters since. 1,709 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Point72 (DIFC) held 408,664 shares of Boston Scientific worth $39.9M as of Q3 2025.
  • Point72 (DIFC) bought 262,364 Boston Scientific shares in Q3 2025, an estimated $27.2M.
  • Boston Scientific made up 2.61% of Point72 (DIFC)'s portfolio in Q3 2025, its #4 holding.
  • Point72 (DIFC) first reported a position in Boston Scientific in Q4 2024 and has held it in 4 quarters since.
  • 1,709 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.